Batavia
Batavia Biosciences is expanding with a second building at the Leiden Bio Science Park.
Since its foundation in 2010, Batavia has been developing vaccines and medicines at the LBSP against, among other things, advancing viruses such as corona. The new building, which will be located opposite Corpus on the A44, is mainly intended to scale up production.
Completed
-
2023-2024
Run time
-
Life, Science & Health
Type
-
Universiteit Leiden
Landowner
-
12.000 vierkante meter
Surface area
-
Flexibele laboratoria Zonnepanelen
Unique Features
- Architect Paul de Ruijter Architecten
- Project documents